Biotechnology Medicare’s Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Eurozone Granolas 11 Vs. Magnificent 7: Low Volatility, Higher Yields – AstraZeneca (NASDAQ:AZN), ASML Holding (NASDAQ:ASML) Read more
Biotechnology This Analyst Slightly Lowers AstraZeneca Forecast Amid Earnings Concerns, Although Still Bullish on Future Growth Potential – AstraZeneca (NASDAQ:AZN) Read more
Stockmarkets Astrazeneca says Catalent deal shows need for in-house capacity Reuters via biedexmarkets.com Read more
Biotechnology Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Biden Administration To Send Pharma Companies Opening Offers For Medicare Program’s First Ever Drug Price Negotiations – AstraZeneca (NASDAQ:AZN), AbbVie (NYSE:ABBV) Read more